Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Which properties make a neuroleptic "atypical"?].

G Gründer1, I Vernaleken, O Benkert

  • 1Psychiatrische Klinik und Poliklinik, Universität Mainz, Untere Zahlbacher Strasse 8, 55131 Mainz. gruender@mail.uni-mainz.de

Der Nervenarzt
|January 5, 2002
PubMed
Summary

Atypical neuroleptics are a diverse group of drugs, not a single class. Their "atypical" properties stem from various pharmacological mechanisms, including combined dopamine and serotonin receptor antagonism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic reference range for duloxetine in the treatment of depression revised: A systematic review and meta-analysis.

Neuroscience applied·2025
Same author

Venlafaxine's therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis.

Psychopharmacology·2023
Same author

Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder.

European archives of psychiatry and clinical neuroscience·2022
Same author

Correction to: Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia.

The Psychiatric quarterly·2022
Same author

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2021
Same author

Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia.

The Psychiatric quarterly·2020

Area of Science:

  • Pharmacology and Neuroscience
  • Psychiatry

Context:

  • The classification of neuroleptic drugs into "conventional" and "atypical" categories is complex.
  • A spectrum exists between conventional and atypical neuroleptics, challenging rigid categorization.
  • Preclinical data and neuroimaging studies (SPECT, PET) provide insights into neuroleptic mechanisms.

Purpose:

  • To discuss the prevailing concepts of neuroleptic "atypicality" based on pharmacological and clinical data.
  • To explore the diverse biological mechanisms underlying the actions of atypical neuroleptics.

Summary:

  • Atypical neuroleptics are pharmacologically and clinically heterogeneous, not a single homogeneous class.
  • Key features of atypicality include combined D2-like dopamine/5-HT2-serotonin antagonism and mesolimbic dopamine neuron binding.

Related Experiment Videos

  • Other mechanisms like specific neurotransmitter receptor affinities, non-dopaminergic interactions, low D2 affinity, and dopamine autoreceptor binding contribute to atypicality.

    • Impact:

    • There is no single, unified pharmacological definition for "atypicality" in neuroleptics.
    • The diverse mechanisms highlight the heterogeneity of atypical neuroleptic compounds.
    • Substantial clinical differences among these substances reflect their varied biological underpinnings.